NO990722D0 - FremgangsmÕte for behandling av hjertesvikt - Google Patents

FremgangsmÕte for behandling av hjertesvikt

Info

Publication number
NO990722D0
NO990722D0 NO990722A NO990722A NO990722D0 NO 990722 D0 NO990722 D0 NO 990722D0 NO 990722 A NO990722 A NO 990722A NO 990722 A NO990722 A NO 990722A NO 990722 D0 NO990722 D0 NO 990722D0
Authority
NO
Norway
Prior art keywords
procedure
treatment
heart failure
heart
failure
Prior art date
Application number
NO990722A
Other languages
English (en)
Other versions
NO990722L (no
Inventor
Yuhpyng Liang Chen
Anthony Andrea Fossa
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO990722D0 publication Critical patent/NO990722D0/no
Publication of NO990722L publication Critical patent/NO990722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO990722A 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt NO990722L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (2)

Publication Number Publication Date
NO990722D0 true NO990722D0 (no) 1999-02-16
NO990722L NO990722L (no) 1999-08-18

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990722A NO990722L (no) 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt

Country Status (28)

Country Link
US (1) US6043260A (no)
EP (1) EP0951906A1 (no)
JP (1) JPH11292766A (no)
KR (1) KR19990072616A (no)
CN (1) CN1231176A (no)
AP (1) AP9901464A0 (no)
AR (1) AR017723A1 (no)
AU (1) AU1732999A (no)
BG (1) BG103180A (no)
BR (1) BR9900653A (no)
CA (1) CA2262252C (no)
EA (1) EA199900124A3 (no)
GT (1) GT199900015A (no)
HR (1) HRP990054A2 (no)
HU (1) HUP9900386A3 (no)
ID (1) ID23218A (no)
IL (1) IL128531A0 (no)
IS (1) IS4975A (no)
MA (1) MA26608A1 (no)
NO (1) NO990722L (no)
OA (1) OA10976A (no)
PA (1) PA8467401A1 (no)
PE (1) PE20000266A1 (no)
PL (1) PL331507A1 (no)
SG (1) SG81261A1 (no)
TN (1) TNSN99024A1 (no)
TR (1) TR199900328A2 (no)
ZA (1) ZA991220B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US7067664B1 (en) 1995-06-06 2006-06-27 Pfizer Inc. Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
US6585995B1 (en) * 1999-09-21 2003-07-01 Hanson Stephen R Methods and compositions for treating platelet-related disorders
EP1263732A1 (en) * 2000-01-18 2002-12-11 Pfizer Products Inc. Corticotropin releasing factor antagonists
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
JP2005532268A (ja) 2002-02-22 2005-10-27 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換されたピリミジノンおよびピリミジンチオン
BR0308391A (pt) * 2002-03-13 2005-01-11 Pharmacia & Upjohn Co Llc Derivados de pirazolo(1,5-a)piridina como moduladores neurotransmissores
MXPA04008384A (es) * 2002-04-26 2004-11-26 Upjohn Co Derivados de pirazina sustituidos.
US20040116444A1 (en) * 2002-09-12 2004-06-17 Corbett Jeffrey W. Substituted 1,4-pyrazine derivatives
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
AU2003278542A1 (en) * 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc Pyrazine compounds as crf modulators
WO2004094408A1 (en) * 2003-04-23 2004-11-04 Pharmacia & Upjohn Company Llc Substituted pyrimidinones and pyrimidinthiones as crf antagonists
JP2006525309A (ja) * 2003-05-07 2006-11-09 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロロ（１，２−ｂ）ピリダジン化合物、ならびにＣＲＦ−１受容体拮抗薬としてのその使用
WO2004099201A1 (en) * 2003-05-09 2004-11-18 Pharmacia & Upjohn Company Llc Compounds as crf1 receptor antagonists
CA2525195A1 (en) * 2003-05-09 2004-11-18 Pharmacia & Upjohn Company Llc Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
CA2524352A1 (en) * 2003-05-09 2004-11-18 Pharmacia & Upjohn Company Llc Substituted pyrimidine derivatives
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
IL128531A0 (en) 2000-01-31
CA2262252A1 (en) 1999-08-17
MA26608A1 (fr) 2004-12-20
NO990722L (no) 1999-08-18
PL331507A1 (en) 1999-08-30
AP9901464A0 (en) 1999-03-31
JPH11292766A (ja) 1999-10-26
TNSN99024A1 (fr) 2005-11-10
OA10976A (en) 2001-11-05
EP0951906A1 (en) 1999-10-27
PE20000266A1 (es) 2000-04-07
AR017723A1 (es) 2001-09-12
BR9900653A (pt) 2000-10-17
ZA991220B (en) 2000-08-16
CA2262252C (en) 2006-01-10
KR19990072616A (ko) 1999-09-27
ID23218A (id) 2000-03-30
HUP9900386A2 (hu) 1999-11-29
TR199900328A2 (xx) 1999-10-21
HRP990054A2 (en) 2000-02-29
AU1732999A (en) 1999-09-02
EA199900124A2 (ru) 1999-08-26
CN1231176A (zh) 1999-10-13
BG103180A (bg) 1999-09-30
GT199900015A (es) 2000-07-26
HUP9900386A3 (en) 1999-12-28
PA8467401A1 (es) 2000-09-29
EA199900124A3 (ru) 1999-12-29
SG81261A1 (en) 2001-06-19
US6043260A (en) 2000-03-28
HU9900386D0 (en) 1999-04-28
IS4975A (is) 1999-08-18

Similar Documents

Publication Publication Date Title
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
FI20000863A (fi) Uusi hoitomenetelmä
PT1235831E (pt) Novos compostos de oxabispidina uteis no tratamento de arritmias cardiacas
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20012106D0 (no) Middel for behandling av benpatobolisme
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO982014L (no) Fremgangsmåte for beregning av varighet av oppkoblinger
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
NO20014026D0 (no) Krampestillende derivater til behandling av betydelig skjelving
ATE261965T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
NO996166L (no) FremgangsmÕte for behandling av avluter